Patent ID: 11958906
Assignee: GENENTECH, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 7:
8. The pharmaceutical composition of claim 7, wherein:
(a) the pharmaceutical composition is determined to be stable if the pharmaceutical composition maintains a purity that is changed by less than 5% as measured by SE-H PLC;
(b) the pharmaceutical composition has a purity of about 85% or higher as assessed by SE-HPLC;
(c) the purity of the pharmaceutical composition as assessed by SE-HPLC is maintained about the same for about 36 months or longer at about 5° C.;
(d) the pharmaceutical composition is determined to be stable if the pharmaceutical composition maintains a purity that is changed by less than 5% as measured by non-reduced CE-SDS assay;
(e) the pharmaceutical composition has a purity of about 75% or higher as assessed by non-reduced CE-SDS assay; or
(f) the purity of the pharmaceutical composition as assessed by non-reduced CE-SDS assay is maintained for about 36 months or longer at about 5° C.